MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 56 filers reported holding MARKER THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $54,000 | +285.7% | 161,818 | +397.9% | 0.00% | – |
| Q1 2022 | $14,000 | -89.0% | 32,500 | -75.6% | 0.00% | – |
| Q4 2021 | $127,000 | -21.6% | 133,305 | +38.6% | 0.00% | – |
| Q3 2021 | $162,000 | -86.7% | 96,174 | -78.0% | 0.00% | – |
| Q2 2021 | $1,217,000 | +6.6% | 436,334 | -14.4% | 0.00% | – |
| Q1 2021 | $1,142,000 | +884.5% | 509,707 | +536.0% | 0.00% | – |
| Q4 2020 | $116,000 | +1.8% | 80,142 | +5.0% | 0.00% | – |
| Q3 2020 | $114,000 | -32.1% | 76,342 | -5.6% | 0.00% | – |
| Q2 2020 | $168,000 | +17.5% | 80,881 | +7.3% | 0.00% | – |
| Q1 2020 | $143,000 | -86.1% | 75,400 | -62.4% | 0.00% | – |
| Q3 2019 | $1,026,000 | +342.2% | 200,711 | +587.4% | 0.00% | – |
| Q2 2019 | $232,000 | +139.2% | 29,200 | +66.9% | 0.00% | – |
| Q4 2018 | $97,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,142,857 | $2,986,000 | 1.05% |
| ACT CAPITAL MANAGEMENT, LLC | 354,400 | $337,000 | 0.24% |
| NEA Management Company, LLC | 10,714,285 | $10,179,000 | 0.21% |
| Long Focus Capital Management, LLC | 1,233,257 | $1,172,000 | 0.16% |
| Mandatum Life Insurance Co Ltd | 99,000 | $94,000 | 0.02% |
| MATRIX ASSET ADVISORS INC/NY | 150,000 | $143,000 | 0.02% |
| AR ASSET MANAGEMENT INC | 71,500 | $68,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 590,118 | $561,000 | 0.01% |
| WealthTrust Axiom LLC | 22,700 | $21,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 324,216 | $308,000 | 0.01% |